Related Experiment Video
Updated: Jul 13, 2026

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease
Published on: May 22, 2026
Left ventricle diastolic dysfunction in obese patients with newly diagnosed arterial hypertension
Viktor Persic1, Alen Ruzic, Bojan Miletic
1Department of Cardiology, Thalassotherapia Opatija, M. Tita 188, 51410 Opatija, Croatia.
Insights
Newly diagnosed arterial hypertension significantly impairs left ventricular diastolic function in obese patients. This occurs before detectable structural changes, highlighting early intervention needs for cardiovascular health.
Area of Science:
- Cardiology
- Obesity Medicine
- Diagnostic Imaging
Background:
- Obesity and arterial hypertension frequently coexist and are independent risk factors for diastolic dysfunction.
- Limited data exists on diastolic dysfunction in obese patients with newly diagnosed hypertension.
Purpose of the Study:
- To determine the prevalence of diastolic dysfunction in obese individuals with newly diagnosed arterial hypertension.
- To compare diastolic function in this group with normotensive obese individuals.
Main Methods:
- 125 obese patients were enrolled: 65 with new hypertension, 60 normotensive controls matched for age, sex, and BMI.
- Doppler-echocardiography assessed left ventricular diastolic function using mitral inflow velocities, E/A ratio, and other parameters.
- Diastolic dysfunction was defined by an E/A ratio <1.
Main Results:
- Obese patients with new hypertension showed higher A wave, lower E/A ratio, longer E deceleration time, and larger left atria.
- No significant differences were found in E wave peak velocities, left ventricle heart mass, or hypertrophy prevalence.
- The prevalence of diastolic dysfunction was significantly higher in the newly hypertensive obese group.
Conclusions:
- Newly diagnosed arterial hypertension contributes to impaired left ventricular diastolic function in obese patients.
- This impairment occurs before structural echocardiographic changes become apparent.
- Early detection and management of hypertension in obese individuals are crucial for preserving diastolic function.
Background:
The frequent coexistence of obesity and arterial hypertension is well known. Although both conditions have been identified as independent risk factors for impaired left ventricular diastolic function, there is a paucity of data on the dysfunction among obese patients with newly diagnosed arterial hypertension. The study was performed to determine the prevalence of diastolic dysfunction in obese individuals with newly diagnosed arterial hypertension and to compare it with the prevalence in normotensive obese persons.
Methods:
We enrolled 125 obese patients: 65 with newly diagnosed hypertension and 60 normotensive patients matched for age, sex and body mass index. Left ventricular diastolic function was assessed from the following Doppler-echocardiographic measurements: mitral inflow velocities (E and A wave), E wave deceleration time, isovolumetric relaxation time, left atrial and left ventricular diameters, left ventricular wall thickness and left ventricular heart mass index. Diastolic dysfunction was considered when the E/A ratio was <1.
Results:
We found significantly higher A wave, lower E/A ratio, longer E deceleration time and a bigger left atrium in obese patients with newly diagnosed arterial hypertension. We did not find significant differences in E wave peak velocities between the two groups. Although there was no difference in left ventricle heart mass or the prevalence of left ventricle hypertrophy, the prevalence of diastolic dysfunction was higher in the group with newly diagnosed arterial hypertension.
Conclusion:
This study suggests that newly diagnosed arterial hypertension significantly contributes to impairment of left ventricular diastolic function in obese patients before development of structural aberrations detectable on echocardiography.
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation III: Medical Management
Pathophysiology of Heart Failure
Mitral Regurgitation I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies

